Technical Analysis for DVA - DaVita HealthCare Partners Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Range Bar | Range Expansion | 0.88% | |
Multiple of Ten Bullish | Other | 0.88% | |
Overbought Stochastic | Strength | 0.88% | |
NR7 | Range Contraction | -1.85% | |
NR7-2 | Range Contraction | -1.85% | |
Gapped Up | Strength | -1.85% | |
Overbought Stochastic | Strength | -1.85% | |
New 52 Week Closing High | Bullish | -2.13% |
Alert | Time |
---|---|
Possible Inside Day | about 14 hours ago |
Up 1% | about 18 hours ago |
Down 2 ATRs | 1 day ago |
Down 3% | 1 day ago |
Down 2 % | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: 02/11/2025
DaVita HealthCare Partners Inc. Description
DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. It primarily operates kidney dialysis centers; and provides acute inpatient dialysis and related lab services primarily in dialysis centers and contracted hospitals. The company offers outpatient, home-based, and hospital inpatient hemodialysis services; ESRD laboratory services; and operates or provides management and administrative services to outpatient dialysis centers that are minority owned by the company or wholly owned by third parties. In addition, the company offers DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; infusion therapy services; disease management services; vascular access services; ESRD clinical research programs; and physician services, as well as manages and operates medical groups and physician networks in California, Nevada, Florida and New Mexico. As of December 31, 2012, it operated or provided administrative services through 1,954 outpatient dialysis centers in 44 states in the United States and the District of Columbia. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Classification
Sector: Healthcare
Industry: Medical Care
Keywords: S&P 500 Medicine Clinical Medicine Disease Clinical Research Dialysis Membrane Technology End Stage Renal Disease Hemodialysis Laboratory Services Vascular Access Products Nephrology Renal Disease Stage Renal Disease Therapy Services Renal Dialysis Disease Management Kidney Dialysis Kidney Failure Medical Groups Rockwell Medical Disease Management Services Lab Services Physician Services Infusion Therapy
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 179.6 |
52 Week Low | 108.76 |
Average Volume | 631,224 |
200-Day Moving Average | 151.09 |
50-Day Moving Average | 161.45 |
20-Day Moving Average | 169.83 |
10-Day Moving Average | 175.21 |
Average True Range | 4.02 |
RSI (14) | 61.83 |
ADX | 37.17 |
+DI | 25.02 |
-DI | 19.74 |
Chandelier Exit (Long, 3 ATRs) | 167.55 |
Chandelier Exit (Short, 3 ATRs) | 163.15 |
Upper Bollinger Bands | 183.34 |
Lower Bollinger Band | 156.33 |
Percent B (%b) | 0.64 |
BandWidth | 15.90 |
MACD Line | 4.79 |
MACD Signal Line | 4.89 |
MACD Histogram | -0.0982 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 179.26 | ||||
Resistance 3 (R3) | 178.97 | 176.78 | 178.31 | ||
Resistance 2 (R2) | 176.78 | 175.33 | 176.93 | 178.00 | |
Resistance 1 (R1) | 175.18 | 174.44 | 175.98 | 175.47 | 177.68 |
Pivot Point | 173.00 | 173.00 | 173.40 | 173.14 | 173.00 |
Support 1 (S1) | 171.40 | 171.55 | 172.20 | 171.69 | 169.48 |
Support 2 (S2) | 169.21 | 170.66 | 169.36 | 169.16 | |
Support 3 (S3) | 167.61 | 169.21 | 168.85 | ||
Support 4 (S4) | 167.90 |